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Abstract
In protein-coding genes, synonymous mutations are often thought not to affect fitness and therefore are not subject to
natural selection. Yet increasingly, cases of non-neutral evolution at certain synonymous sites were reported over the last
decade. To evaluate the extent and the nature of site-specific selection on synonymous codons, we computed the site-to-
site synonymous rate variation (SRV) and identified gene properties that make SRV more likely in a large database of
protein-coding gene families and protein domains. To our knowledge, this is the first study that explores the determinants
and patterns of the SRV in real data. We show that the SRV is widespread in the evolution of protein-coding sequences,
putting in doubt the validity of the synonymous rate as a standard neutral proxy. While protein domains rarely undergo
adaptive evolution, the SRV appears to play important role in optimizing the domain function at the level of DNA. In
contrast, protein families are more likely to evolve by positive selection, but are less likely to exhibit SRV. Stronger SRV was
detected in genes with stronger codon bias and tRNA reusage, those coding for proteins with larger number of interactions
or forming larger number of structures, located in intracellular components and those involved in typically conserved
complex processes and functions. Genes with extreme SRV show higher expression levels in nearly all tissues. This indicates
that codon bias in a gene, which often correlates with gene expression, may often be a site-specific phenomenon regulating
the speed of translation along the sequence, consistent with the co-translational folding hypothesis. Strikingly, genes with
SRV were strongly overrepresented for metabolic pathways and those associated with several genetic diseases, particularly
cancers and diabetes.
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Introduction
Synonymous mutations in protein-coding genes preserve an
encoded amino acid (AA), and so by Anfinsen’s principle [1],
should not affect the protein product. Presumably having no
fitness effect, synonymous mutations therefore should be invisible
to natural selection. However, it has long been suggested that
translational selection on synonymous codon usage may act to
adapt to organism’s tRNA pools [2,3]. In many genes and
organisms, differences in abundance of cognate tRNAs for
different synonymous codons lead to selection pressure to
maximize translation rate in favor of codons that that are read
by the most abundant tRNA [4,5,6]. Therefore, the key signature
of translational selection is the codon bias in favor of optimal
codons affecting whole genes, where fast accurate translation
ensures high levels of expression. More recently, experimental
studies showed that rare codons may also be favored and selection
could act differentially at different synonymous sites, even within
the same gene. For example, rare codons may be more frequent in
genes with low level of expression, if slow translation is more
favorable [7], or involved in regulating expression levels over the
time course [8]. Overall, several stages prior to translation
involved in protein production may be sensitive to codon choice
[9]. Today overwhelming evidences indicate that synonymous
mutations can be under site-specific selection on synonymous
codon choice. Synonymous mutations can affect splicing control
elements, such as exonic splicing enhancers and silencers [10,11]
and even can create new ‘cryptic’ splice sites [12], and so will be
affected by selection to avoid codons that could be incorrectly
identified as intronic ends. To ensure correct splicing, selection
may constrain the synonymous rates of evolution in domains
associated with splice control [13,14] and in alternatively spliced
exons [15,16,17]. Constraints on synonymous changes help to
ensure efficient binding of microRNA to sense mRNA as a mode
of gene regulation [9]. Plenty of studies indicate that synonymous
mutations can have direct effect on mRNA structure stability,
often causing drastic phenotypic effect [18,19,20]. Perhaps even
more surprisingly, synonymous mutations can affect the protein
folding. Kimchi-Sarfaty and colleagues [21] demonstrated that a
synonymous change in the multidrug resistance-1 gene (MDR-1)
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causes protein misfolding. The protein with the new altered form
helps the cancer cells to get rid of the chemotherapy drug much
more efficiently, making the drug useless [21]. Indeed, the folding
of a peptide chain is somewhat speed-dependent, and slower
production influences the final 3D form of the protein product.
Translational pausing due to the usage of rare codons explains
why stretches of rare codons were found to correlate to turns, loops
and links between protein domains [22,23].
In sum, it is now evident that synonymous mutations can be
under a variety of selective mechanisms. With over 40 genetic
diseases (including cancers and diabetes) associated with synony-
mous mutations, it is now clear that such mutations can have
important fitness consequences, unlike previously thought [24,25].
Chamary and Hurst [26] estimated that 5–10% of human genes
contain at least one region where silent mutations could be
harmful. Based on the analysis of human genetic associations of
SNPs with disease, Chen et al. [27] concluded that non-
synonymous and synonymous SNPs show similar likelihood and
effect size of human disease association. Finally, synonymous
mutations may be responsible for individual differences in disease
susceptibility and treatment outcomes (see [25] for a comprehen-
sive review).
Recently, many large-scale statistical studies focused on
detecting pervasive positive diversifying selection on the protein,
as measured by the nonsynonymous to synonymous rates ratio
v= dN/dS [28]. However, patterns of selection on synonymous
codons are poorly understood. Most often negative selection on
synonymous codons is studied by measuring the average codon
usage per gene. Resch et al. [29] performed a large-scale scan for
positive selection on synonymous sites, where average pairwise
synonymous substitution rate dS for a gene was compared to the
corresponding average intron rate in mouse-rat gene pairs. This
approach found that positive selection on synonymous sites could
be even more frequent than positive selection on the protein.
However, the pairwise averaging approach typically lacks power
[30] and overlooks the impact of site-specific synonymous rate
variation (SRV) over the protein-coding sequence. Zhou et al. [31]
proposed to distinguish synonymous rates of change between
different types of synonymous codons (‘‘preferred’’ and ‘‘un-
preferred’’). Applied to yeast and worm genes, their method found
substantially lower number of genes with positive selection on
synonymous sites compared to [29]. Clearly, the accuracy of such
an approach would be affected by uncertainties in identifying
preferred and un-preferred codons. But perhaps more important-
ly, the method of Zhou et al. [31] models only average
synonymous rates per gene and so cannot capture site-specific
selection pressure that acts on the DNA or mRNA level related to
transcription, splicing, expression regulation or mRNA structure
stability. Significant variation of synonymous rates (dS) reflects that
the evolutionary forces act differently at different synonymous
sites, likely due to variation in selective constraints. Thus candidate
genes affected by either purifying or positive selection on the DNA
can be detected with a systematic analysis of the SRV, using the
extent of dS variation as a proxy for selection.
Here for the first time we present a large-scale analysis of
homologous proteins – with the aim to improve our understanding
of the nature of synonymous changes and the SRV in protein-
coding sequences. In contrast to the study of Resch et al. [29], we
analyzed multiple sequence alignments (where evolutionary
information is at the maximum) using Markov codon models with
SRV. We determined how often and where strong SRV occurs,
and listed the gene properties that make the SRV more likely. The
patterns of SRV and groups of genes enriched with SRV may
provide important clues for other studies focusing on understand-
ing disease, optimizing transgene design, as well as those dedicated
to determining specific and general evolutionary trends in
molecular sequences. Our study opens directions for exploring
new measures of selective pressure that incorporate the effect of
selection on synonymous sites.
Materials and Methods
The Data
7738 homologous groups and corresponding alignments of
protein-coding DNA and AA sequences were obtained from the
PANDIT database v17.0 [32]; http://www.ebi.ac.uk/goldman-
srv/pandit). PANDIT contains protein domains and families,
derived from the Pfam-A seed alignments [33]. Phylogenetic trees
were inferred for each homologous group by maximum likelihood
(ML) under the amino acid model LG+C+F, as implemented in
PhyML3.0 [34]. These ML estimates of trees were consequently
used for all optimizations under codon models (see below). To
avoid drawing conclusions based on saturated alignments, we
removed groups where the average divergence was greater than
two expected substitutions per amino acid site per branch (Figure
S1). Annotations for each homologous group were taken from the
PANDITplus database [35]; http://panditplus.org), an extension
of PANDIT, integrating data from a variety of reliable and
curated bioinformatics sources. It provides access to data on
protein interactions, functional and chemical pathway annotation,
gene expression and association with diseases. The estimates from
evolutionary codon models computed for this study are now also
available from PANDITplus.
Analyses of Positive Selection (PS) on the Protein and the
Synonymous Rate Variation (SRV)
Pervasive diversifying positive selection (PS) on the protein was
evaluated by ML using Markov models of codon evolution, as
implemented in the codeml program from the PAML package
v4.1 [36]. The selective pressure at the protein level was measured
by the v-ratio, with v,1, = 1, or .1 indicating purifying, neutral
or positive selection on the protein respectively [37]. For each
homologous group we computed estimates of the average v using
model M0, which assumes constant selective pressure across codon
sites and over time. ML estimates of branch lengths under M0
were then used as starting (or fixed) values in all following
computations under codon models. Likelihood ratio test (LRTs) of
nested codon models M0 vs M3, and M7 vs M8 was used to
determine whether a gene was affected by selection [38,39,40].
Evidence for adaptive evolution in a gene was considered sufficient
if the following conditions were met: (1) both LRTs were
significant at 5% level with an estimated v.1, (2) the estimated
proportion of positively selected sites was large enough to include
at least one site, and (3) the SRV-aware model (DUAL, [41])
supported the presence of PS. Condition (3) was required to avoid
a potential bias on the detection of PS as a result of SRV. Groups
of proteins with evidence of PS are further refereed to as PS+,
while those with no such evidence are denoted as PS2.
To determine whether a gene exhibited site-to-site SRV, we
applied an LRT between a codon model where dS was assumed
constant (model M3) and a model where both dS and dN could vary
(DUAL model) [41]. ML optimization for this task was performed
with the HYPHY program [41]. Both dS and dN were assumed to
be drawn from independent general discrete distributions, each
with three rate categories. Evidence for site-to-site SRV was
considered sufficient if: (1) the LRT was significant at 5% level and
(2) the coefficient of variation (CV) of the synonymous rates was .
0. The second condition was added to exclude the few cases with
Site-to-Site Synonymous Rates Variation
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artifacts of ML estimation, where the LRT showed significantly
better fit of the model with variable dS, but yet the estimated CV of
dS was 0. Data classified as having significant SRV is further
referred to as SRV+ set, while data where dS can be assumed
constant is further referred to as SRV2.
Patterns in 7341 data sets were analyzed, after filtering out
protein groups that were too diverged or had convergence
problems during ML optimizations. To avoid optimization
problems each analysis was performed multiple times and one
with a higher log-likelihood was selected.
Analyses of Over/Under-representation in Functional
Categories
GO and KEGG annotations for each group were obtained from
PANDITplus [35]. To account for the hierarchical nature of GO
and KEGG data, each gene (protein) was considered to belong to
all parent categories where it was directly assigned. To test the
over/under-representation of genes with specific feature (PS or
SRV), the data sets were divided into two groups: those showing
evidence for the feature of interest (PS+, SRV+) and those that
failed to show such evidence (PS2, SRV2). For each tested
functional category C, a 262 contingency table was constructed
containing the numbers of genes assigned and not assigned to C.
To test for independence of rows and columns one-sided P-values
were computed using Fisher’s exact test. As test sets overlapped,
the raw P-values from Fisher’s exact test were adjusted to control
the false discovery rates [42].
Codon Bias, Autocorrelation and Nucleotide Composition
For each protein group, we computed total GC content, GC
content at third codon positions (GC3), and codon usage indices
CBI (Codon Bias Index, [43]) and ENC (Effective Number of
Codons, [44]), using the CodonW program [45]. CBI measures
the usage of optimal codons, ranging between 1 (only optimal
codons are used) to 21 (only non-optimal codons are used), with 0
for random codon choice. ENC is another measure of synonymous
codon usage, ranging between 20 (only one codon is used for each
AA) and 61 (codons are used randomly).
Finally, we computed the TPI (tRNA Pairing Index), a statistical
measure of tRNA reusage [46,47], using the dedicated Darwin
functions [48]. By definition, the TPI ranges from 21 for perfectly
anticorrelated tRNA changes (i.e maximal number of tRNA
changes) to +1 for perfectly autocorrelated (minimal number of
tRNA changes). For example, in a sequence where one AA is
encoded by two tRNAs X and Y, highly autocorrelated case is
XXXXYYYY, while XYXYXY is highly anticorrelated case. For
a comprehensive review of codon usage measures see [49].
Note that when measuring the correlation between any two
phenomena, we computed both Spearman and Pearson correla-
tion coefficients, which provided very similar results. We therefore
show only the Spearman correlation values.
Analyses of Gene Expression Data
Several sources of gene expression data were used in this study.
Mappings of gene expression in human tissues (data from
HumanProteinpedia [50]) were obtained from PANDITplus.
These data do not contain information on the expression levels,
but only inform whether a gene is expressed in a certain human
tissue or not. Fisher’s exact tests were performed to identify the
tissues with over/under-representation of expressed genes with
SRV and PS. Information on human gene expression breadth of
Ensembl genes from three types of experiments (Gene Atlas
microarray, EST and SAGE) was taken from [51]. These data
provide information on the gene expression breadth measured by
the number of tissues where the gene is expressed, but no
information about the expression levels or the tissue of expression.
Ensembl gene IDs were mapped to Pfam IDs using BioMart
module of the Ensembl database v.62 [52]. Note that in the
expression data analyses we used gene-Pfam mappings derived
from gene associations with full Pfam alignments. We also
analyzed expression data from Gene Atlas U133A Affymetrix
microarray from the BioGPS portal of the Genomics Institute of
the Novartis Research Foundation ([53]; http://biogps.gnf.org/
downloads), mapping individual protein sequences from the seed
PANDIT alignments to microarray probes. We used these data to
analyze gene expression levels by calculating the distribution of the
log expression values for the categories of interests.
Clustering Analyses
Hierarchical clustering of gene categories was performed for
KEGG pathways. The dissimilarity matrix for the clustering was
defined so that any two categories A and B from the same
hierarchical level had dissimilarity dAB= 0 when all SRV+ genes
were assigned to both categories A and B, and dissimilarity dAB= 1
when A and B did not share any SRV+ gene. More specifically,
dissimilarity between two categories A and B was defined as:
dAB~
1{jN(A)\N(B)j
minN(A),N(B)
where N(X) denotes the number of SRV+ genes in category X.
Results
Significant SRV was found in 42% (or 37%) of protein groups
at 5% (or 1%) significance level. This suggests that the
phenomenon of site-to-site heterogeneity of synonymous rates is
widespread and deserves attention. Extreme SRV was detected in
154 datasets (CV$1, see Table S1). Notably, certain Pfam clans
were exclusively composed of SRV+ groups. Recall that clans are
higher-level clusters of related families, grouped based on
structure, function, matching of families HMMs and profile-
profile comparisons. The list of SRV exclusive clans includes p53-
related proteins and ABC transporters (see Table S2).
Note that PS on the protein was detected in 11% (or 7%) of
groups at 5% (or 1%) significance level (consistent with previous
estimates, eg. [54]). We observed weak but significant negative
correlation (r=20.11, P,10216) between the variability of
synonymous rates and the average v-ratio across protein sites.
This indicates that proteins that are more conserved tend to have
greater SRV among sites. A bootstrap analysis on the differences
in mean v for protein groups classified as SRV+ and SRV2,
confirmed that proteins with SRV tend to be under stronger
purifying selection (lower v) compared to proteins where
synonymous rates may be assumed constant (Figure 1A).
Reflecting Pfam, our protein groups included protein families
(74%), domains (23%), motifs (1%) and repeats (2%). SRV was
significantly overrepresented in protein domains, but underrepre-
sented in protein families (Table 1). An opposite pattern was
observed for PS: protein domains showed significant underrepre-
sentation of groups with PS, while protein families were
overrepresented with PS+ groups. Motifs and repeats did not
show any significance for over or underrepresentation with SRV+
or PS+ groups, most likely due to their small dataset numbers and
short sequences, which increased variance of ML estimates.
Site-to-Site Synonymous Rates Variation
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Figure 1. Bootstrap distribution of the differences in A) the mean v-ratio, B) tRNA reusage, measured through tRNA Pairing Index
(TPI), C) number of interactions and D) number of structures, between protein groups having site-to-site variation in synonymous
rates (SRV+) and protein groups having constant synonymous rates (SRV2). The plots B), C) and D) also show the bootstrap distributions
of the corresponding differences between protein groups showing evidence for positive selection (PS+) and those failing to show such evidence
(PS2). All differences (except for TPI in PS+/PS2 data) are significant since 95% of the histogram area does not include the zero value.
doi:10.1371/journal.pone.0095034.g001
Table 1. Overrepresentation (+) and underrepresentation (2) of SRV and PS in different data categories.
Pfam type SRV PS
Representation P-value Representation P-value
Protein Domains + 10233 2 1029
Protein Families 2 10228 + 10210
doi:10.1371/journal.pone.0095034.t001
Site-to-Site Synonymous Rates Variation
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Dependencies between Site-to-site SRV and Gene
Properties
Selection for translational speed favors codons matching the
cognate tRNA profile. We investigated whether the codon bias
and tRNA reusage could contribute to the observed site-to-site
SRV. CV of synonymous rates was correlated with both codon
bias and tRNA reusage (Table S3). In the SRV+ group the
average codon bias and tRNA reusage were significantly larger
than in the SRV2 group (Figure 1B; Figure S2, Table 2). In
contrast PS+ group had on average weaker codon bias compared
to the PS2 group (Table 2, Figure S2).
It has been suggested that selection at synonymous sites favors
high GC, which is reflected in a correlation between codon bias
and GC3, the GC content at third codon positions [55]. Some
studies reported that GC at synonymous sites was higher than in
the flanking introns [56,57], and that GC content could contribute
to the regulation of splicing signals, in which case synonymous
mutations may lead to exon skipping associated with disease [58].
These evidences indicate the possibility of selection acting on
synonymous sites. In our data we observed that the variability of dS
correlated positively with the variation of GC and GC3 among
homologous genes, but not very well with the GC and GC3
content (see also Figure S3 and Table S3).
Our results suggest that proteins with many interactions evolved
under stricter purifying selection (Figure 1C), which is in
agreement with the extended complexity hypothesis [54]. We
observed positive correlation between the number of interactions
and CV of dS (r=0.22, P,10
216; Figure 1C). Since SRV and PS
groups were unequally represented within different data types
(domains, families, motifs and repeats), bootstrap analyses were
repeated for each data type separately. The reported trends were
significant for domains, families and repeats. Further, proteins
forming many structural complexes exhibited stronger SRV
(Figure 1D) and tended to be more conserved and less likely to
be under recurrent diversifying positive selection. We observed
positive correlation between the number of structural complexes
that proteins can form and the CV of dS (r=0.22, P,10
216), and
weak negative correlation with the v-ratio (rSpearman =20.08, P,
10212; Pearson correlation was not significant).
Overall, our data show that there is a correlation between the
individual variables, most notable between GC and GC3 content
(r=0.92); codon bias and GC3 content (r=0.74); codon bias and
GC content (r=0.73); number of interactions and number of
structures (r=0.52); codon bias and codon autocorrelation
(r=0.41); GC content and codon autocorrelation (r=0.23) etc.
However, some of these variables could be independently
associated with one another. For instance, it has been widely
reported that codon bias is associated with various biological
factors, such as gene expression level, tRNA abundance, GC
composition, protein structure etc. Furthermore, it was shown that
the similarity in codon usage is a strong predictor of protein-
protein interactions [59]. To get more insights, we conducted a
multivariate analysis and sought to find the individual variables
that give the greatest separations between the SRV+ and SRV2
groups. We quantified the ‘‘separation’’ F between the SRV+ and
SRV2 groups achieved by a particular variable (v-ratio, CBI,
TPI, GC/GC3 content, #interactions, #structures) as the ratio of
its ‘‘between-groups’’ variance to its ‘‘within-groups’’ variance.
Surprisingly, the greatest separation between the two groups was
achieved based on the number of protein-protein interactions
(F = 218), followed by the tRNA reusage index (F= 193), the
number of protein structures (F = 146), the v-ratio (F= 74), codon
bias (F= 68), GC3 content (F= 30) and GC content (F= 16).
Finally, we performed principal component analysis (PCA) to
investigate whether most of the variation between our SRV+/
SRV2 data can be captured using principal components that
were linear combinations of all or some of the other variables (v-
ratio, CBI, TPI, GC/GC3 content, #interactions, #structures).
The first two principal components (PC) explain 70% of the
variance of SRV. The first PC (explaining 45% of the variance)
represented a contrast between the v-ratio and the other
variables (CBI, TPI, GC content, GC3 content, #interactions,
#structures), with the largest loadings (in absolute) values for
GC3 content (0.59), GC content (0.59) and CBI (0.55), the
loadings of the other components were ,0.06. This supports the
negative correlation between CV of SRV and the v-ratio, and its
positive correlation with all the other variables, but suggests that
omega has little impact (based on the low loading value). The
second PC represents a contrast between the v-ratio, CBI, TPI,
#interactions and #structures, and the variables GC content and
GC3 content. The largest loadings of this PC were for
#interactions (0.7), #structures (0.7), while the loadings (in
absolute) values of the other variables were ,0.08. Overall, the
PCA demonstrates that the influence of the above-mentioned
factors on SRV is complex due to the strong dependencies among
them.
Table 2. Differences between the mean values of the attribute (#interactions, #structures, codon bias and tRNA reusage) in SRV+
and SRV2 data, and in PS+ and PS2 data correspondingly.
Attribute
Difference between attribute means
in SRV+ and SRV2 data (median [IQR])
Difference between attribute means in
PS+ and PS2 data (median [IQR])
Interactions 0.50 [0.48, 0.53 20.42 [20.44, 20.39]
Structures 17.72 [16.65, 18.80] 211.38 [210.12, 212.59]
Codon bias (CBI measure) 0.02 [0.019; 0.022] 20.01 [20.018; 20.011]
Codon bias (ENC measure) 21.3 [21.39; 21.22] 1.0 [0.84; 1.18]
tRNA reusage 0.14 [0.13; 0.15] 20.01 [20.02; 0.005]
GC content 0.042 [0.04; 0.043] 20.041 [20.038; 20.043]
GC3 content 0.08 [0.078; 0.083], 20.08 [20.085; 20.076]
All p-values are,10216, except for the differences in mean values of tRNA reusage (TPI) between PS+/PS2 data where there was no significance. This table corresponds
to Figure 1 and Figure S2.
doi:10.1371/journal.pone.0095034.t002
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Site-to-site SRV and Protein Function, Interactions and
Reaction Networks
We examined the distribution of GO functional categories [60]
with respect to site-to-site SRV. Since our protein groups were
unevenly distributed among GO categories (Figure S4), significant
over/under-representation was more difficult to detect for sparsely
sampled categories, with better power for GO terms annotating
larger number of protein groups.
Table 3 summarizes the results of GO-enrichment tests for
‘‘Cellular Component’’. Categories enriched with SRV+ proteins
included cell envelope, membrane, wall and external encapsulat-
ing structure. Underrepresentation of SRV+ proteins was found in
extracellular region, membrane-enclosed lumen and organelles.
Our results for PS+ proteins are consistent with previous findings
[54,61]: extracellular region and MHC protein complex were
found as overrepresented with PS+ proteins, while the cellular
components that are mostly internal to the cell, organelles and
macromolecular complex were identified as strongly conserved.
Analyses of ‘‘Molecular function’’ categories are summarized in
Table 4. Categories enriched with SRV+ proteins included
catalytic and transporter proteins, proteins with a role in carrying
electrons, or those important for binding (with exception of
receptor binding). Underrepresentation of SRV+ proteins was
observed among the proteins that participate in receptor binding
and enzyme regulation. Categories underrepresented with PS+
proteins included catalytic and transporter proteins, and those
with a role in binding.
Enrichment analyses of ‘‘Biological process’’ categories are
summarized in Table 5. We found an overrepresentation of SRV+
among the proteins with function in metabolism, cellular processes
and in localization and transport. Proteins that participate in
multi-organism processes (symbiosis, interaction with host), defen-
sive response to stimulus and reproduction were found as least
likely to have significant site-to-site SRV. For PS+ proteins we
observed the opposite: proteins involved in metabolic and cellular
processes, as well as biological regulation were found to be most
conserved and least likely to undergo adaptive evolution. Proteins
related to immune system processes and response to stimulus,
which represent obvious targets for adaptive evolution, were
enriched with PS.
Table 3. Over/under-representation of selective forces in GO categories for Cellular Component.
GO Categories SRV PS #pfam
Over(+)/Under(2)
represent. Signif.
Over(+)/Under(2)
represent. Signif.
cellular component
extracellular region 2 *** + *** 205
cell + ** 2 ** 1491
cell part + ** 2 ** 1491
intracellular 2 ** 872
membrane + * 717
cell wall + * 29
cell envelope + ** 38
endomembrane system 2 ** 55
external encapsulating structure + ** 63
intracellular part 2 ** 773
extrachromosomal DNA + ** 6
ribonucleoprotein complex + * 116
virion + *** 151
virion part + ** 141
viral capsid + * 98
viral envelope + * 35
membrane-enclosed lumen 2 ** 25
organelle lumen 2 ** 23
intracellular organelle lumen 2 ** 23
macromolecular complex 2 * 346
ribosome 2 ** 98
MHC protein complex + ** 4
organelle 2 *** 2 ** 597
membrane-bounded organelle 2 *** 2 * 423
intracellular membrane-bounded organelle 2 *** 2 * 420
intracellular organelle 2 *** 2 ** 593
Notation: Significance levels are at the 5% (*), 1% (**), or 0.1% (***). Boldface indicates overrepresentation of SRV; italics indicates underrepresentation of SRV.
doi:10.1371/journal.pone.0095034.t003
Site-to-Site Synonymous Rates Variation
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These findings suggest that forces driving either SRV or PS are
not independent from the gene function, with distinct biases in
their distribution among GO categories. Furthermore, with
exception of organelles, there was a visible tendency to observe
enrichment with SRV+ proteins in the same GO categories that
were underrepresented with PS (Tables 3–5).
Information on biological pathways, in which a protein is
involved, includes chemical reactions within a cell whose
dependencies and dynamics are distinct from the notion of a
biological process as classified by GO. Therefore, we also
performed enrichment analyses for 18,041 human genes in
KEGG with respect to their biological pathways (Table 6). We
classified a KEGG gene as being affected by PS (or SRV), if it was
mapped to at least one PANDIT group that was classified as PS+
(or SRV+ respectively).
SRV+ genes were found to be enriched for a wide variety of
functions related to metabolic pathways, particularly in carbohy-
drate and amino acid metabolism, metabolism of cofactors and
vitamins, metabolism of xenobiotics by cytochrome and drug
metabolism - cytochrome. This finding is consistent with our
observations about metabolic processes based on GO. However,
the analyses of KEGG pathways also revealed certain metabolic
pathways where SRV+ genes were underrepresented. This result
might be due to the fact that gene ontologies are not equivalent to
pathways: pathways could involve genes that are not directly
relevant to the metabolic process, but are included because of the
pathway inter-process dependencies and specific dynamics.
Additionally, this may be also due to the fact that KEGG analysis
is done only on human genes, unlike GO.
Our analyses of GO terms identified that metabolic processes
were generally conserved. Studies of positive selection on the
protein level [54,61,62] mainly refer to metabolic processes, but
not to metabolic pathways. The differences in our results from
KEGG and GO for positive selection might be due to the way of
classification of KEGG genes as PS+ (having found at least one
PANDIT data product of that gene as positively selected). Namely,
Table 4. Over/under-representation of selective forces in GO categories for Molecular Function.
GO Categories SRV PS #pfam
Over(+)/Under(2)
represent. Signif.
Over(+)/
Under(2)
represent. Signif.
molecular function
electron carrier activity + * 53
catalytic activity + *** 2 *** 1536
oxidoreductase activity + ** 2 *** 251
transferase activity + * 2 * 444
transferase activity, transferring one-carbon groups 2 ** 76
hydrolase activity + *** 533
isomerase activity + *** 58
ligase activity + *** 75
ligase activity, forming carbon-oxygen bonds + *** 25
structural molecule activity 220
structural constituent of ribosome 2 ** 98
transporter activity + ** 2 * 221
binding + *** 2 *** 1286
nucleotide binding + *** 2 ** 263
purine nucleotide binding + *** 2 * 231
ribonucleotide binding + *** 2 * 217
protein binding 2 * 244
receptor binding 2 * 83
nucleoside binding + *** 2 * 200
purine nucleoside binding + *** 2 * 199
nucleic acid binding + ** 2 *** 515
DNA binding 2 ** 368
carbohydrate binding + * 27
ion binding 2 ** 270
cation binding 2 ** 269
cofactor binding + *** 61
coenzyme binding + *** 47
enzyme regulator activity 2 ** 68
Notation: Significance levels are at the 5% (*), 1% (**), or 0.1% (***). Boldface indicates overrepresentation of SRV; italics indicates underrepresentation of SRV.
doi:10.1371/journal.pone.0095034.t004
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Table 5. Over/under-representation of selective forces in GO categories for Biological Processes.
GO Categories SRV PS #pfam
Over(+)/
Under(2)
represen. Signif.
Over(+)/
Under(2)
represent. Signif.
biological process
reproduction 2 ** + * 130
metabolic process + *** 2 *** 1807
oxidation reduction 2 ** 98
nitrogen compound metabolic process + *** 2 *** 883
amine metabolic process + *** 2 * 127
cellular nitrogen compound metabolic process + * 2 *** 840
biosynthetic process + *** 2 *** 879
macromolecule biosynthetic process + * 2 *** 591
regulation of biosynthetic process 2 ** 231
cellular biosynthetic process + ** 2 *** 838
regulation of metabolic process 2 ** 260
macromolecule metabolic process + *** 2 *** 1022
gene expression + *** 2 *** 62
macromolecule biosynthetic process + *** 2 *** 591
protein metabolic process + *** 2 *** 378
cellular macromolecule metabolic process + *** 2 *** 875
cellular metabolic process + *** 2 *** 1383
organic acid metabolic process + *** 139
cellular amino acid and derivative metabolic process + *** 2 * 113
cellular nitrogen compound metabolic process + ** 2 *** 840
cellular ketone metabolic process + *** 2 ** 139
cellular biosynthetic process + *** 2 *** 838
cellular macromolecule metabolic process + *** 2 *** 875
cellular carbohydrate metabolic process + *** 102
primary metabolic process + *** 2 *** 1409
carbohydrate metabolic process + *** 228
nucleobase, nucleoside, nucleotide and nucl. acid m. proc. 2 *** 696
cellular amino acid and derivative metabolic process + *** 2 * 113
protein metabolic process + *** 2 *** 378
small molecule metabolic process + *** 2 * 349
alcohol metabolic process + ** 64
organic acid metabolic process + *** 139
cellular amino acid and derivative metabolic process + *** 2 * 113
cellular ketone metabolic process + *** 2 ** 139
immune system process + ** 27
immune response + *** 26
antigen processing and presentation + ** 4
viral reproduction 123
viral reproductive process
viral assembly, maturation, egress, and release + * 25
virion assembly + * 20
viral capsid assembly + * 10
cellular process + *** 2 *** 1782
cell communication 2 * 35
cellular metabolic process + *** 2 *** 1383
regulation of cellular process 2 ** 332
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a gene is annotated for all the functions and processes of its
products, so it may happen that positive selection in a gene is due
to positive selection only in a certain protein domain while the
signal for positive selection will be tracked for all the functions and
processes that the gene is annotated, i.e. all the pathway
annotations of its products.
Further, we found an overrepresentation of SRV among the
genes participating in some genetic and environmental informa-
tion processing pathways. We observed underrepresentation of PS
among the genes involved in genetic information processing
pathways, but overrepresentation of PS among the genes involved
in environmental information processing pathways.
Among the cellular processes, cell motility and communication,
endocrine and sensory system, and developmental pathways were
found to be overrepresented with SRV+ genes. Categories
overrepresented with PS+ genes included cell communication
and immune and sensory system pathways. These findings are
generally consistent with our previous findings for SRV in cellular
processes using GO annotations. However, note that the
hierarchical structure of cellular processes in KEGG and GO
databases is different. For example, GO terms for immune system
processes are not ‘‘descendants’’ of terms for cellular processes,
while in KEGG cellular process pathways include immune,
nervous and sensory system pathways. Therefore, a simple
comparison of trends for cellular processes in KEGG and GO is
not possible without looking into the finer sub-categories. If the
immune, nervous and sensory system pathways were excluded
from the KEGG cellular process pathways, then overrepresenta-
tion of PS+ in the cellular processes group could not be observed.
Generally, significant overrepresentation of SRV was found
among genes involved in human diseases. SRV+ genes were
enriched in cancer related pathways (Figure 2). Very strong
overrepresentation of SRV+ genes was also found in metabolic
disorders (type II diabetes mellitus) and immune disorders
(systemic lupus erythematosus). Underrepresentation of genes with
SRV was detected among genes involved in neurodegenerative
disease pathways. Immune and metabolic disorders pathways
exhibited an overrepresentation of PS+ genes.
Site-to-site SRV and Gene Expression Patterns
To test if SRV+ genes are over/underrepresented among the
genes expressed in different human tissues, we analyzed gene
expression data of 8,175 human genes from HumanProteinpedia
(HPRD) expressed in 57 healthy and 20 disease tissues, which were
uniquely mapped to KEGG genes. Significant evidence of
overrepresentation of SRV+ genes was found among genes
expressed in brain, cerebrospinal fluid, liver and pancreatic juice.
Among the genes expressed in blood plasma there was an
overrepresentation of PS+ genes, while conserved genes were
overrepresented among the genes expressed in brain, ovary and
stem cell. Indeed, in a previous study genes expressed in the brain
were among the most conserved genes with the least evidence for
PS [61]. Note that in that study blood plasma was not analyzed as
a separate tissue.
Further, we tested for possible relation between gene expression
breadth, measured by the number of expression tissues, and the
SRV/PS forces. Several studies report that broadly expressed
genes evolve more slowly than tissue specific genes (eg. [63,64]).
The power for detecting such correlation is very limited with the
HPRD data, as it is skewed towards low expression breaths (Figure
S5). Therefore, to analyze the correlation between gene expression
breadth and SRV/PS we used data from [51] that mapped
Ensembl gene IDs to gene expression breadth values estimated
from Gene Atlas microarray, EST and SAGE experiments for
Table 5. Cont.
GO Categories SRV PS #pfam
Over(+)/
Under(2)
represen. Signif.
Over(+)/
Under(2)
represent. Signif.
cellular localization 2 *** 85
developmental process + * 89
response to stimulus + ** 202
response to stress + * 132
defense response 2 ** + *** 36
response to wounding + ** 9
immune response + *** 26
localization + *** 2 ** 360
macromolecule localization 2 ** 104
establishment of localization + *** 2 ** 344
cellular localization 2 *** 85
multi-organism process 2 ** + *** 142
pathogenesis + ** 71
biological regulation 2 ** 384
regulation of biological process 2 ** 356
regulation of metabolic process 2 ** 260
regulation of cellular process 2 ** 332
Notation: Significance levels are at the 5% (*), 1% (**), or 0.1% (***). Boldface indicates overrepresentation of SRV; italics indicates underrepresentation of SRV.
doi:10.1371/journal.pone.0095034.t005
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Table 6. Over/under-representation of selective forces in KEGG Pathways.
KEGG Pathway SRV PS
Over(+)/
Under(2)
represen. Sign. #Genes
Over(+)/
Under(2)
represen. Sign. #Genes
Metabolism 1434 2 ** 1484
Carbohydrate Metabolism + * 300 313
Pentose phosphate pathway + ** 26 26
Pentose and glucuronate interconversions 25 + *** 25
Fructose and mannose metabolism + * 34 36
Ascorbate and aldarate metabolism 26 + *** 26
Starch and sucrose metabolism + ** 54 + *** 54
Inositol phosphate metabolism + ** 51 51
Energy Metabolism 2 *** 170 2 *** 178
Oxidative phosphorylation 2 *** 116 124
Nitrogen metabolism + * 24 24
Lipid Metabolism 317 330
Androgen and estrogen metabolism + * 44 + *** 46
alpha-Linolenic acid metabolism 2 ** 17 + * 17
Amino Acid Metabolism + * 295 303
Glycine, serine and threonine metabolism + ** 41 41
Glycan Biosynthesis and Metabolism 2 *** 206 213
Glycosaminoglycan degradation 18 + * 18
Glycosphingolipid biosynthesis - globoseries 2 *** 14 14
Glycosphingolipid biosynthesis - ganglioseries 2 *** 21 21
Metabolism of Cofactors and Vitamins + * 190 204
Retinol metabolism + * 56 + *** 65
Porphyrin and chlorophyll metabolism 41 + *** 41
Xenobiotics Biodegradation and Metabolism 156 + *** 160
Metabolism of xenobiotics by cytochrome P450 + *** 66 + *** 70
Drug metabolism - cytochrome P450 + *** 68 + *** 72
Drug metabolism - other enzymes 52 + *** 52
Genetic Information Processing + * 560 2 *** 573
Translation 143 143
Aminoacyl-tRNA biosynthesis + ** 40 40
Folding, Sorting and Degradation + * 257 264
Ubiquitin mediated proteolysis + * 125 2 *** 132
SNARE interactions in vesicular transport + * 37 37
Regulation of autophagy 2 ** 34 + *** 34
Environmental Information Processing + *** 1434 + *** 1480
Membrane Transport + *** 42 42
ABC transporters + *** 42 42
Signal Transduction + *** 849 892
MAPK signaling pathway + *** 265 272
ErbB signaling pathway + *** 85 85
Calcium signaling pathway + *** 170 181
Phosphatidylinositol signaling system + *** 69 75
Hedgehog signaling pathway + * 56 57
Jak-STAT signaling pathway 2 *** 126 145
Signaling Molecules and Interaction + *** 729 + *** 750
Neuroactive ligand-receptor interaction + ** 292 + *** 295
ECM-receptor interaction + * 84 + *** 84
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Table 6. Cont.
KEGG Pathway SRV PS
Over(+)/
Under(2)
represen. Sign. #Genes
Over(+)/
Under(2)
represen. Sign. #Genes
Cell adhesion molecules (CAMs) + *** 128 + *** 130
Cellular Processes + *** 1774 + *** 1837
Cell Motility + *** 201 213
Regulation of actin cytoskeleton + *** 201 213
Cell Growth and Death 210 2 * 225
Cell Communication + *** 400 + *** 413
Focal adhesion + *** 193 201
Adherens junction + ** 77 78
Tight junction + *** 116 + *** 128
Gap junction + *** 96 96
Endocrine System + * 369 381
Insulin signaling pathway + * 129 136
Melanogenesis + *** 96 102
Adipocytokine signaling pathway 61 2 * 66
Immune System 519 + *** 547
Antigen processing and presentation 2 * 82 + *** 86
Natural killer cell mediated cytotoxicity 132 + *** 139
Leukocyte transendothelial migration + *** 109 + *** 117
Sensory System + *** 416 + *** 429
Olfactory transduction + *** 370 + *** 381
Taste transduction + * 51 + *** 53
Development + *** 124 129
Axon guidance + *** 124 129
Human Diseases + *** 983 1025
Cancers + *** 365 378
Pathways in cancer + *** 305 312
Colorectal cancer + *** 83 83
Endometrial cancer + ** 50 50
Basal cell carcinoma + *** 54 55
Melanoma + *** 68 69
Immune Disorders + ** 225 + * 229
Asthma 30 + *** 30
Autoimmune thyroid disease 53 + *** 53
Systemic lupus erythematosus + *** 143 143
Allograft rejection 38 + *** 38
Graft-versus-host disease 42 + *** 42
Neurodegenerative Diseases 275 297
Alzheimer’s disease 2 ** 145 162
Parkinson’s disease 2 *** 116 124
Huntington’s disease 2 ** 162 172
Metabolic Disorders + *** 96 + ** 104
Type II diabetes mellitus + *** 42 43
Type I diabetes mellitus 42 + *** 44
Infectious Diseases + *** 147 149
Pathogenic Escherichia coli infection + ** 53 53
Notation: Significance levels are at the 5% (*), 1% (**), or 0.1% (***). Boldface indicates overrepresentation of SRV; italics indicates underrepresentation of SRV.
doi:10.1371/journal.pone.0095034.t006
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human tissues. Our analyses revealed negative correlation between
expression breadth and the average CV of dS (r=20.81, P= 0.02)
and the average v-ratio (r=20.79, P= 0.02) using Gene Atlas
microarray data (Figure S6). Similar results were obtained using
SAGE and EST data (Figure S7–S8).
Additionally, we used expression measurements in 86 tissues
from Gene Atlas Affymetrix U133A microarray. 4,095 proteins
that were classified into SRV+/2 and PS+/2 groups were
mapped to the microarray probes. We examined mRNA
expression levels of SRV+ and SRV2 genes and observed no
difference. However, genes with extreme SRV (CV $ 0.8),
showed increased expression levels in nearly all tissues. There were
243 such genes and we refer to them as SRVEXT genes. We
compared the distribution of the expression levels of the SRVEXT
gene group to the distribution of the expression levels of the
SRV2 genes. The differences were the most pronounced in
several neural tissues: hypothalamus, medulla oblongata, occipital
lobe, pineal day, pineal night, prefrontal cortex, spinal cord,
amygdala, caudate nucleus, cingulate cortex, fetal brain, whole
brain. Figure 3A shows the differences in the distribution of the
Figure 2. Hierarchical clustering of human disease and environmental information processing pathways in respect to the SRV+
genes that are shared between the pathways. The bars next to the pathways denote the number of SRV+ genes (red) and SRV- genes (green) in
the corresponding pathways. Cancer related pathways are marked in blue; metabolic disease pathways are in purple. Note that ABC transporters and
Type II diabetes mellitus pathways are exclusively composed of SRV+ genes.
doi:10.1371/journal.pone.0095034.g002
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expression levels in several tissues. The observed differences
remained when we compared the distribution of the expression
levels of the SRVEXT genes to the distribution of the expression
levels of the SRV2 genes including the subgroup of SRV+ genes
where CV of dS was ,0.8. Consistently with the study of Kosiol et
al. [61], we observed decreased expression levels of PS+ genes in
all tissues (Figure 3B). Using this gene expression dataset we
observed significant overrepresentation of SRV among the genes
expressed in small intestine, pancreas, tongue and several brain
tissues. With the Gene Atlas Affymetrix microarray data
cerebrospinal fluid and pancreatic juice were not experimentally
tested as separate tissues.
Discussion
Large-scale scans for adaptively evolving genes have provided
valuable insights into the patterns of positive selection in protein-
coding genes, but have left many important questions unanswered.
In coding sequences selection may also operate on synonymous
sites, contributing to significant variability patterns with respect to
the conservation of the synonymous substitution rate and codon
usage.
Our analyses of protein families and domains revealed that the
site-to-site SRV is a ubiquitous phenomenon affecting over a
third of homologous protein domains and families. Strikingly, our
study suggests that variation in synonymous rates is more likely in
genes that are conserved and are least likely to undergo
adaptation at the protein level. Proteins with significant SRV
are involved in complex functions, exhibit stronger codon bias
and tRNA reusage, have larger number of interactions and
participate in forming a larger number of structural complexes.
In contrast, we found that genes affected by positive selection
tend to have weaker codon bias and fewer interaction partners
and form fewer protein complexes. This is consistent with the
previous findings: several studies found that the connectivity of
proteins in the network is negatively correlated with their rate of
evolution [54,65,66].
It has been suggested that proteins with more interactions
evolve more slowly because different interactions typically depend
on different sites, and so a greater part of the protein is under
strong functional constraint [65]. At sites important for interaction
between proteins, evolutionary changes may occur largely by co-
evolution, in which substitutions in one protein result in selection
pressure for reciprocal changes in interacting partners. While we
found weak negative correlation between the strength of positive
selection and the number of structural complexes, this was not
found significant in [54], most likely because at that time the
number of structural complexes in Pfam was underestimated (with
fewer structures known) and due to smaller size of PANDIT.
However, it was shown that families and protein domains that
form at least one structure tend to be more conserved. This could
suggest that selection acts on all members of the complex,
irrespective of the number of complexes formed by each member
of the complex [54].
Another surprising finding of our study is that positive selection
on the protein tends to be in an antagonistic relationship with
forces responsible for the SRV 2 a trend seen in most of our
analyses of gene features (codon/tRNA bias, expression, function).
For example, protein domains (very stable protein units optimized
Figure 3. Distribution of the expression levels in A) SRV2 genes (blue) and SRVEXT genes (red) and B) PS2 genes (green) and PS+
genes (purple) for different tissues. SRVEXT genes show higher expression levels compared to SRV2 genes; PS+ genes show reduced expression
levels compared to PS2 genes.
doi:10.1371/journal.pone.0095034.g003
Site-to-Site Synonymous Rates Variation
PLOS ONE | www.plosone.org 13 June 2014 | Volume 9 | Issue 6 | e95034
through deep evolutionary times) evolve slowly compared to
protein families (which often evolve under changing evolutionary
constraints after gene duplications). Here we found that domains
were less likely to undergo positive selection on the protein, but
more likely to have SRV. Possibly for domains, protein ‘‘building
blocks’’ that are reused in different protein architectures, the
exploration of the synonymous mutational landscape is the best
way of fine-tuning the already well-optimized amino acid
sequence. In contrast, protein families were found to be more
likely to undergo positive selection on the protein, but less likely to
have significant SRV. Gene ontologies enriched with SRV were
often underrepresented with PS.
This may suggest that site-to-site variation of synonymous rates
and codon bias are more likely to produce more subtle effects on
protein transcription and translation, and so the SRV might be
one of the mechanisms of adaptation in the proteins that evolve
slowly. Indeed, in very conserved proteins most (if not all)
nonsynonymous mutations would result in a dysfunctional protein
product and would be selected against. The exploration of
mutational landscape is then possible mostly through synonymous
mutations. For example, depending on the position in a sequence
the use of rare (or optimal) codons may slow down (or speed up)
the translation, which can be crucial for correct protein folding
[67]. In another example, differences in mRNA stability were
attributed to synonymous mutations in the conserved gene lady bird
early (lbe) from the homeobox cluster of Drosophila melanogaster [68].
This example is consistent with our observations: on lbe balancing
selection on synonymous sites acts at the background of strict
purifying selection on the protein.
Crucially, the understanding of protein function requires a
detailed analysis of sequence-structure-function trinity. Here we
focused on sequences with SRV, a phenomenon that may affect
protein folding, abundance, degradation and function - through
the regulation of translational rate or mRNA stability. In our
study, proteins found in the cell interior (with exception of
organelles) tended to have more SRV, while it was observed less
frequently in proteins located in the extracellular region. Again,
this pattern is opposite to the well-known localization pattern for
proteins whose protein encoding sequences are under positive
selection on the protein level. Furthermore, proteins involved in
metabolic and cellular processes, transporter activities and binding
exhibited significant excess of SRV.
Several pathways are especially rich in genes with SRV,
suggesting that selective forces on synonymous sites may frequently
act directly on whole protein complexes or pathways. This can be
seen from our clustering of SRV genes by KEGG terms, where
several disease pathways and related environmental information
processing pathways frequently share many genes with SRV
(Figure 2). This is supported by recent literature reporting known
associations of synonymous mutations with .40 human diseases
[24].
Alternatively, some studies suggested that adaptive changes in
one protein may sometimes have a cascade effect, leading to
changes in other genes that bring a system back into the
equilibrium [69]. Further investigation in this respect is needed
in order to analyze the effects of the synonymous changes along
the pathway and to reveal the reasons for overrepresentation of
genes with SRV in certain pathways.
Genes expressed in certain tissues (brain, cerebrospinal fluid,
liver, pancreatic juice) showed excess of SRV. Moreover, genes
with extreme SRV had increased expression levels in most of the
human tissues, especially in brain tissues. This may indicate that
codon bias towards optimal codons, which correlates with gene
expression, may not affect all sites, but is often a site-specific
phenomenon. Indeed, as mentioned above, variation in usage of
optimal vs rare codons could act as a mechanism for regulating the
speed of translation along the sequence, consistent with the co-
translational folding hypothesis. Some recent studies suggested
that site-specific codon preferences may be better explained by
pressures for translational accuracy [70–72] rather than speed of
translation, and the impact of rare codon clusters on ribosomal
occupancy has been recently questioned based on ribosomal
footprinting in yeast [73]. This highlights the complexity of the
relationship between selection on synonymous sites, biochemical
properties of the transcript, protein production and the eventual
function of protein product, necessitating further studies in this
direction.
Recent reports show that synonymous SNPs (synSNPs) can be
associated with disease phenotype, causing disease or be respon-
sible for differences in individual responses to drug treatment. If a
haplotype with a synSNP has higher fitness, it will increase in
frequency due to selection. Growing number of diseases are
associated with synonymous polymorphisms, such as several types
of cancers, hyperinsulinism of infancy, diabetes, and prion-related
conditions, to name a few [24,67,74,75,76,77,78]. Indeed, in our
data we observed high SRV in genes associated with diabetes,
lupus and various cancers. We found significant SRV in several
human genes where synSNPs have been documented to lead or
contribute to a disease [25], among such examples are: the
CHRNE gene, where a synSNP can directly cause a Myastenic
syndrome (muscle disease); the FGFR2 gene, where a synSNP is a
direct cause of a Crouzon syndrome (bone disease); the tumor
suppressor protein p53, where synonymous polymorphisms are
associated with overall tumor susceptibility, pathology and
prognosis; the EGFR gene, where synSNPs may be a potential
predictor for clinical outcome in advanced Non-Small-Cell Lung
carcinoma; the PAH gene, where synSNPs can lead to
Phenylketonuria; the CHRNA4 gene, where synSNPs are
associated with Alzheimer’s disease; in the three genes PADI2,
SYNGR1 and DRD2 associated with schizophrenia. Interesting-
ly, we also detected significant SRV in the MDR-1 gene 2 the
first known case where the effect of a synonymous change on
protein folding was demonstrated in vivo (discussed in the
introduction; [21,79]). Our analyses identified overrepresentation
of SRV in metabolizing enzymes and transporters, which are
subject to many pharmacogenetics studies because they deter-
mine the disposition, safety and efficacy of small molecule drugs
[24].
Overall, the SRV statistic carries a real signal, identifying
important genes including those associated to human disease.
However, like for any automated large-scale study, the conclu-
sions should not be overgeneralized and taken with caution:
hidden effects such as errors in annotation and reduced power of
LRTs for small or too divergent alignments may have contributed
to the overall signal (indeed in our data correlation was found
with number of taxa and divergence, although weak and clearly
non-linear (see Figure S9)). The possibility that size/divergence of
alignments may cause variation in power of LRT for positive
selection (which are methodologically quite similar to the LRT
for SRV that we used here) has been thoroughly studied in [38]
using computer simulations. The study showed that for small
alignments and too low/deep divergences the LRT remained
accurate but had decreased power. To check that this did not bias
our results, we repeated all analyzes by removing small
alignments (in different combinations) with and without a
threshold of $0.3 on the CV of SRV. We could confirm the
reported trends in all cases.
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Whole-genome investigations on a fixed number of lineages
would help to reduce some of the above-mentioned effects.
Further, to detect positions affected by site-specific selection on
synonymous changes with sufficient confidence, better models
and tests need to be developed, taking into account site-to-site
codon variability. Better understanding of site-specific synony-
mous variability promises to become an important contribution
to revising the central molecular biology concepts, to improving
structural prediction, and to our understanding of genetic
diseases with respect to potential effects of synonymous
mutations.
Supporting Information
Figure S1 Histogram of PANDIT data sets divergence.
The divergence (expected substitutions per amino acid site per
branch) was calculated as AA tree length divided by 2*T-3, where
T is the number of sequences in the PANDIT data set. The AA
tree length and the number of sequences in the each data set were
extracted from PANDIT.
(TIF)
Figure S2 Bootstrap distributions of the differences in
mean values of A) Codon Bias Indices (CBI) and B)
Effective Number of Codons (ENC) between protein
groups showing evidence for site-to-site variation in
synonymous rates (SRV+) and those failing to show such
evidence (SRV2), and protein groups showing evidence
for positive selection (PS+) and those failing to show
such evidence (PS2). The differences are significant, since 95%
of the histogram area does not include the zero value for all
histograms.
(TIF)
Figure S3 Bootstrap distributions of the differences
in A) mean GC content values and B) GC3 content
values between PANDIT members showing evidence
for site-to-site variation in synonymous rates (SRV+)
and those failing to show such evidence (SRV2), and
PANDIT members showing evidence for positive
selection (PS+) and those failing to show such
evidence (PS2). All the differences are significant, since 95%
of the histogram area does not include the zero value for all
histograms.
(TIF)
Figure S4 Distributions of data in GO terms.
(TIF)
Figure S5 Expression breadth histogram of genes in
HumanProteinpedia Database.
(TIF)
Figure S6 Correlation between gene expression
breadth (number of tissues of gene expression) calcu-
lated from human Gene Atlas microarray data and A)
average CV of synonymous rates and B) average v
ratio, calculated for each bin of 10 tissues. The Gene
Atlas microarray expression breadth values were taken from
Necsulea et al. (2009).
(TIF)
Figure S7 Correlation between gene expression breadth
(number of tissues of gene expression) calculated from
human SAGE data and A) average CV of synonymous
rates and B) average v ratio. The SAGE gene expression
breadth values were taken from Necsulea et al. (2009).
(TIF)
Figure S8 Correlation between gene expression breadth
(number of tissues of gene expression) calculated from
human EST data and A) average CV of synonymous rates
and B) average v ratio. The EST gene expression breadth
values were taken from Necsulea et al. (2009).
(TIF)
Figure S9 Correlation between individual variables
(stated in the diagonal). The numbers in the upper-diagonal
plots denote the correlation coefficients for the corresponding pairs
of variables. The lower-diagonal plots represent plots of the
corresponding data.
(TIF)
Table S1 PFAM protein groups with extreme site-to-site
heterogeneity of synonymous rates (coefficient of vari-
ation (CV) $1).
(XLS)
Table S2 Clans that are exclusively composed of PFAM
groups identified as having site-to-site heterogeneity of
synonymous rates (SRV+).
(XLS)
Table S3 Strength of correlation between codon bias,
tRNA reusage and nucleotide composition and SRV/PS.
Note that negative correlation with ENC indicates positive
correlation to codon bias, since, unlike CBI, smaller ENC
indicates stronger codon bias.
(XLS)
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